The effects of cisatracurium are antagonized by acetylcholinesterase inhibitors such as neostigmine. Cisatracurium has no dose-related effects on mean arterial blood pressure (MAP) or heart rate following doses ranging from 2â8 times ED95 (> 0.1 to > 0.4 mg/kg) in healthy adult patients or in patients with serious cardiovascular disease.